<TEXT>&#2;<DATELINE>2018-03-31</DATELINE><TITLE>157 Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy</TITLE><BODY>&#3;</BODY></TEXT>